Background: Febrile seizure is convulsions with fever (temperature ³38°C) with no central nervous system infection that commonly found in children (6-60 months). Febrile seizures do not always mean the child has epilepsy. However, febrile seizures can be a possible long-term risk factor for epilepsy. Objective: The objective of this study is to know the profile of febrile seizure in patients with epilepsy. Methods: A retrospective descriptive study on 23 patients with epilepsy in the EEG Department of Neurology, Dr. Soetomo General Hospital, Surabaya, Indonesia in the period 2018-2019 based on inclusion and exclusion criteria. The total number of epilepsy patients is 849 patients, 216 of whom had a history of febrile seizure. Among 216 epilepsy patients who had a history of febrile seizures, 23 of them were qualified as the sample. The sampling technique used was total population sampling. The instrument of this research is the patients’ medical record. Data analysis is carried out descriptively. Results: The characteristics of the history of febrile seizures that found in patients with epilepsy are more patients are male, have the age of onset on less than 2 years old, have the body temperature more than 38.3°C, have the seizure duration less than 15 minutes, have focal seizures, have recurrent seizures in 24 hours, have a history of more than one febrile seizure, have accompanying neurological disorders, and have no family history of epilepsy. Conclusion: Febrile seizure is still becoming a concern because there is a possibility that it may develop into epilepsy. Even though, not all children who experience febrile seizure will generate epilepsy.
Introduction: COVID-19 is a disease caused by SARS-CoV-2 (Severe Acute Respiratory Coronavirus 2), an outbreak in the world in 2019 until now. High cholesterol levels correlate with increasing disease severity in SARS-CoV-2 infection because there is a surge of cases in Gianyar Regency, a district of Taro Village. This study aimed to examine the relationship between age and gender to cholesterol levels which are expected to become information for the people of Taro Village as a basis for health screening to prevent comorbid diseases that increase mortality in SARS-CoV-2 infection and increase awareness of the people of Taro Village to maintain health and implement a healthy lifestyle. Method: Capillary blood was taken and then checked for cholesterol levels using a standardized tool on 44 respondents. The cholesterol check was conducted in Gianyar Regency, precisely in Taro Village, Tegalalang District, and Bali. The data obtained will be analyzed using univariate analysis followed by bivariate analysis using the Spearman correlation test for variables of age and cholesterol levels. In contrast, for variables gender and cholesterol levels, the Mann-Whitney test is performed. Results: A total of 44 individual respondents in this study, the distribution of data, namely the age of the repondent is more in the 41-50 year age group, the number of female respondents is 33 or 75.0% of the total respondent, and 70.5% of the respondent or 31 have normal cholesterol levels. The results of the Spearman test on the variables of age and cholesterol levels obtained a P value>0, 05, and the results of the Mann Withney test on the variables gender and cholesterol levels obtained a P value>0, 05. Conclusion: Most taro villagers have normal cholesterol levels obtained as many as 31 people, or 70.5% of the total respondent. It may be influenced by the work factor of taro villagers who work a lot in the agriculture and plantation sectors. Based on the study results, there is also no significant relationship between age and gender with the cholesterol levels of Taro Villagers. However, high cholesterol levels were only found in females as many as five people.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.